Stock Research for ORMP

ORMP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ORMP Stock Chart & Research Data

The ORMP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ORMP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ORMP Due diligence Resources & Stock Charts

The ORMP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ORMP Detailed Price Forecast - CNN Money CNN View ORMP Detailed Summary - Google Finance
Yahoo View ORMP Detailed Summary - Yahoo! Finance Zacks View ORMP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ORMP Trends & Analysis - Trade-Ideas Barrons View ORMP Major Holders - Barrons
NASDAQ View ORMP Call Transcripts - NASDAQ Seeking View ORMP Breaking News & Analysis - Seeking Alpha
Spotlight View ORMP Annual Report - CompanySpotlight.com OTC Report View ORMP OTC Short Report - OTCShortReport.com
TradeKing View ORMP Fundamentals - TradeKing Charts View ORMP SEC Filings - Bar Chart
WSJ View Historical Prices for ORMP - The WSJ Morningstar View Performance/Total Return for ORMP - Morningstar
MarketWatch View the Analyst Estimates for ORMP - MarketWatch CNBC View the Earnings History for ORMP - CNBC
StockMarketWatch View the ORMP Earnings - StockMarketWatch MacroAxis View ORMP Buy or Sell Recommendations - MacroAxis
Bullish View the ORMP Bullish Patterns - American Bulls Short Pains View ORMP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ORMP Stock Mentions - StockTwits PennyStocks View ORMP Stock Mentions - PennyStockTweets
Twitter View ORMP Stock Mentions - Twitter Invest Hub View ORMP Investment Forum News - Investor Hub
Yahoo View ORMP Stock Mentions - Yahoo! Message Board Seeking Alpha View ORMP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ORMP - SECform4.com Insider Cow View Insider Transactions for ORMP - Insider Cow
CNBC View ORMP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ORMP - OTC Markets
Yahoo View Insider Transactions for ORMP - Yahoo! Finance NASDAQ View Institutional Holdings for ORMP - NASDAQ


Stock Charts

FinViz View ORMP Stock Insight & Charts - FinViz.com StockCharts View ORMP Investment Charts - StockCharts.com
BarChart View ORMP Stock Overview & Charts - BarChart Trading View View ORMP User Generated Charts - Trading View




Latest Financial News for ORMP


Oramed Granted Japanese Patent for GLP-1 Analog Capsule
Posted on Tuesday July 24, 2018

NEW YORK, July 24, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent titled, "Methods and Compositions for Oral Administration of Exenatide." The patent covers Oramed's proprietary invention of an oral glucagon-like peptide-1 (GLP-1) analog. Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (PODTM) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center.


Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4
Posted on Tuesday July 17, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 16) Arcus Biosciences Inc (NYSE: RCUS ) BioLife Solutions Inc (NASDAQ: ...


Oramed: Fiscal 3Q Earnings Snapshot
Posted on Thursday July 12, 2018

The Jerusalem-based company said it had a loss of 30 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...


Oramed Announces Closing of $18.1 Million Registered Direct Offering
Posted on Friday July 06, 2018

NEW YORK, July 6, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the closing of its previously-announced registered direct offering with several healthcare-focused institutional investors. Oramed has sold $18.1 million of shares of common stock and warrants to purchase shares of common stock at a combined price of $6.25 per share and related warrant. The securities described above were offered pursuant to a shelf registration statement (File No. 333-215525), which was declared effective by the United States Securities and Exchange Commission ("SEC") on February 2, 2017.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.